A Study to Test if TEV-56286 is Effective in Relieving Multiple System Atrophy (MSA): A Safety and Efficacy Study

Recruiting

Phase 2

TEV-56286A Study to Test if TEV-56286 is Effective in Relieving Multiple System Atrophy (MSA): A Safety and Efficacy Study

Sponsor:

Teva Branded Pharmaceutical Products R&D, Inc.

Code:

NCT06568237

Conditions

Multiple System Atrophy

Eligibility Criteria

Sex: All

Age: 30+

Healthy Volunteers: Not accepted

Interventions

TEV-56286

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-06-01. This information was provided to ClinicalTrials.gov by Teva Branded Pharmaceutical Products R&D, Inc. on 2025-05-22.